FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026
AUSTIN, Texas, Sept. 01, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026 in New York, New York. Rhodes, together with Ken Mobeck, Chief Financial Officer, will also host 1x1 investor meetings at the conference on Tuesday and Wednesday, September 15-16, 2026.
Date: Tuesday, September 15, 2026
Time: 10:30-11:00 AM ET
Format: Presentation
Webcast: https://journey.ct.events/view/678a5096-f9a4-4a67-b503-ad650aca3c59
The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.
About FocalTherics
A recognized global leader in robotic focal therapy, FocalTherics develops, manufactures, and markets minimally invasive medical devices worldwide to treat various conditions using proprietary focused ultrasound technology. The Company’s flagship platform, Focal One® Robotic HIFU, combines advanced imaging, real-time treatment planning, robotic precision, and HIFU technology to deliver personalized focal therapy designed to optimize clinical outcomes while preserving quality of life.
Investor Contact
Louisa Smith
Gilmartin Group
Investor.relations@focalone.com
